Clinical trials
Active, not recruiting Melanoma trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Pfizer | 2 |
| Regeneron Pharmaceuticals | 2 |
| HUYABIO International, LLC. | 1 |
| Incyte Corporation | 1 |
| Instituto do Cancer do Estado de São Paulo | 1 |
| Pierre Fabre Medicament | 1 |
| Vyriad, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 13 |
| Brain Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Neoplasms | 2 |
| Skin Neoplasms | 2 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Renal Cell | 1 |
| Colonic Neoplasms | 1 |
| Glioma | 1 |
| Neoplasm Metastasis | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.